Comparison of efficacy of iontophoresis with glycopyrrolate solution and tap water for palmar/plantar hyperhidrosis

â??Comparative evaluation of efficacy of iontophoresis with glycopyrrolate solution vs tap water for treatment of primary palmar and plantar hyperhidrosisâ??

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046893

Enrollment

Registered

2022-10-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L745- Focal hyperhidrosis

Interventions

Intervention1: 0.04% glycopyrrolate solution iontophoresis: 0.04% glycopyrrolate solution iontophoresis twice weekly for 4 weeks. Control Intervention1: Tap water iontophoresis: Tap water iontophoresi

Eligibility

Inclusion criteria

Inclusion criteria: Individual with palmar and/or plantar hyperhidrosisfor hyperhidrosis.

Exclusion criteria

Exclusion criteria: Individual who are already on treatment for hyperhidrosis. Pregnant women. History of ischaemic heart disease, arrhythmias or narrow angle glaucoma. Individuals with pacemakers or metal implant, cardiac condition and epilepsy.

Design outcomes

Primary

Measure	Time frame
Subjective assessment of hyperhidrosis using hyperhidrosis disease severity scale(HDSS).Timepoint: At the time of enrollment and weekly for 8 weeks.	—

Secondary

Measure	Time frame
Clinical profile of the patient.Timepoint: At the time of enrollment.;Subjective assessment of severity of hyperhidrosis into mild, moderate, severe categories.Timepoint: At the time of enrollment.	—

Countries

India

Contacts

Public ContactDR RANCHIT NARANG

MAHARISHI MARKANDESHWAR MEDICAL COLLEGE AND HOSPITAL, KUMARHATTI, SOLAN

shankervinay54@gmail.com9418454710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026